NCT05243082

Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Oslo University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

A national multicenter prospective study to investigate the feasibility and efficacy of endoscopic ultrasound guided radiofrequency ablation of neuroendocrine pancreatic tumors, WHO Grade 1-2 of 3 cm or less in diameter.

Conditions

• Pancreatic Neuroendocrine Tumors, WHO Grade I-II

Interventions

Type	Name	Description
DEVICE	Radio frequency ablation	Radio frequency ablation of pancreatic neuroendocrine tumors

Timeline

• Start date: 2022-01-14
• Primary completion: 2025-01-14
• Completion: 2029-11-11
• First posted: 2022-02-16
• Last updated: 2023-03-30

Locations

1 site across 1 country: Norway